Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1489 Articles

Chris Lange | Dec 19, 2018 at 11:40 AM EST

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will…

Douglas A. McIntyre | Dec 19, 2018 at 5:24 AM EST

6 Most Important Business News Items Today

Elon Musk previews Los Angeles transportation tunnel, Pfizer and GlaxoSmithKline team up, stock buybacks hit a record this year, and…

Lee Jackson | Dec 17, 2018 at 7:15 AM EST

History Says Santa Claus Rally May Still Be on Its Way

These six Buy-rated stocks that have had a strong year and would be solid additions to portfolios for the end…

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Dec 11, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

The included top analyst upgrades, downgrades and initiations seen on Tuesday Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 27, 2018 at 6:45 AM EST

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019…

Lee Jackson | Nov 26, 2018 at 7:00 AM EST

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

24/7 Wall St. screened the Merrill Lynch research database for stocks rated Buy that pay a dividend and have the…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 8, 2018 at 12:45 PM EST

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to…

Paul Ausick | Nov 7, 2018 at 4:01 PM EST

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Caterpillar, UnitedHealth, Microsoft, and Pfizer lifted the down to 500-point gain Wednesday.

Chris Lange | Nov 6, 2018 at 11:50 AM EST

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination…

Paul Ausick | Nov 2, 2018 at 4:01 PM EDT

Apple, Intel Tank the Dow Friday

Apple, Intel, Pfizer, and Merck were the worst performing Dow stocks on Friday.

Jon C. Ogg | Nov 1, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Thursday included American Eagle Outfitters, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero…

Chris Lange | Oct 30, 2018 at 8:40 AM EDT

Why Pfizer Is Tripping Over Itself With Earnings

Pfizer reported mixed quarterly results before the markets opened on Tuesday and shares retreated in the premarket.

1 … 31 32 33 34 35 … 100

Pfizer : PFE

All Pfizer Articles

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

6 Most Important Business News Items Today

History Says Santa Claus Rally May Still Be on Its Way

Major Pharma Stocks See a Surge in Short Interest

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

Short Sellers Hike Their Bets in Major Pharma Stocks

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Apple, Intel Tank the Dow Friday

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

Why Pfizer Is Tripping Over Itself With Earnings

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Veteran Investor: Talen Energy Is a Double at Minimum, With Triple-Digit Upside as Power Demand Rises

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Retired Couple's Three Pets Are Costing Them $14K a Year. What That Means for Retirement

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Pfizer : PFE

All Pfizer Articles

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

6 Most Important Business News Items Today

History Says Santa Claus Rally May Still Be on Its Way

Major Pharma Stocks See a Surge in Short Interest

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

Short Sellers Hike Their Bets in Major Pharma Stocks

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

UnitedHealth, Caterpillar Launch the Dow Higher Wednesday

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Apple, Intel Tank the Dow Friday

Top Analyst Upgrades and Downgrades: American Eagle, Facebook, Nutrisystem, Pfizer, Roku, SeaWorld, Valero, Zynga and More

Why Pfizer Is Tripping Over Itself With Earnings

The Fed Just Triggered a Sharp Tech-Sector Sell-Off: Here Is the 1 Dirt-Cheap Financial Disruptor I’m Buying Hand Over Fist

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Veteran Investor: Talen Energy Is a Double at Minimum, With Triple-Digit Upside as Power Demand Rises

Featured Reads

He Wants to Spend Retirement Restoring Classic Cars. How Large a Portfolio Does He Need?

Retired Couple's Three Pets Are Costing Them $14K a Year. What That Means for Retirement